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Abstract  
Introduction: Being infected with COVID-19 is associated with direct and indirect effects on the 
cardiopulmonary system and electrocardiography can aid in management of patients through rapid and early 
identification of these adversities.  
Objective: The present study was designed aiming to evaluate electrocardiographic changes and their 
correlation with the outcome of COVID-19 patients.  
Methods: This Prospective cohort study was carried out on COVID-19 cases admitted to the emergency 
department of an educational hospital, during late February and March 2020. Electrocardiographic 
characteristics of patients and their association with in-hospital mortality were investigated.  
Results: One hundred and nineteen cases with the mean age of 60.52±13.45 (range: 29-89) years were 
studied (65.5% male). Dysrhythmia was detected in 22 (18.4%) cases. T-wave inversion (28.6%), pulmonale 
P-wave (19.3%), left axis deviation (19.3%), and ST-segment depression (16.8%) were among the most 
frequently detected electrocardiographic abnormalities, respectively. Twelve (10.1%) cases died. There was a 
significant correlation between in-hospital mortality and history of diabetes mellitus (p=0.007), quick SOFA 
score > 2 (p<0.0001), premature ventricular contraction (PVC) (p=0.003), left axis deviation (LAD) (p=0.039), 
pulmonale P-wave (p<0.001), biphasic P-wave (p<0.001), inverted T-wave (p=0.002), ST-depression 
(p=0.027), and atrioventricular (AV) node block (p=0.002). Multivariate cox regression showed that history of 
diabetes mellitus, and presence of PVC and pulmonale P-wave were independent prognostic factors of 
mortality. 
Conclusions: Based on the findings of the present study, 18.4% of COVID-19 patients had presented with some 
kind of dysrhythmia and in addition to history of diabetes, presence of PVC and pulmonale P-wave were among 
the independent prognostic factors of mortality in COVID-19 patients. 
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INTRODUCTION
More than 3 months has passed from the emergence 
of COVID-19 and studies on ways to prevent this 
disease and treat and improve the outcome of these 
patients are still ongoing. Cardiometabolic changes 
and multi-organ dysfunction are among the 
problems that have been reported following COVID-
19 pneumonia. In addition, there are evidence of 
cardiac involvement and myocarditis in these 
patients, even in the absence of any sign of 
pulmonary parenchyma involvement (1). The 
findings suggest that these adversities worsen the 
disease and increase the probability of mortality in 
patients (2-5). On the other hand, underlying 
cardiovascular disorders have been introduced as a 
risk factor of mortality among COVID-19 patients 
and history of cardiovascular diseases is one of the 
factors that lead to a severe disease (5). Recent 
studies have shown that after being infected with 
COVID-19, cardiac disorders are also observed in 
individuals without a history of cardiac diseases (4). 
For instance, a recent meta-analysis has shown that 
the level of troponin I is significantly higher in cases 
with a severe form of COVID-19 compared to other 
patients (6). It seems that COVID-19 can directly or 
indirectly affect the cardiovascular system and lead 
to myocarditis, myocardial infarction, cardiac 
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ischemia, arrhythmia and thromboembolism and 
thus, affect the outcome of the disease (7). However, 
our knowledge on the cardiac changes that occur 
following COVID-19 is limited. Therefore, 
evaluating electrocardiographic changes in these 
patients could aid in rapid and early detection of 
cardiac adversities. Additionally, if there is a 
correlation between electrocardiography changes 
and outcome of COVID-19, being aware of it can be 
beneficial in management of infected patients. By 
reporting 2 cases with COVID-19, Jia He et al. 
introduced dynamic changes in electrocardiogram 
(ECG) as an index of cardiac injury and critical status 
of these patients (8). A study in China reported that 
around 15.5% of patients with COVID-19 had ECG 
abnormalities and introduced changes in rate, T 
wave changes, atrioventricular (AV) node block, and 
QT changes as the most important observed 
changes (9). Considering the above-mentioned 
points, the present prospective cohort study was 
designed and performed with the aim of evaluating 
electrocardiographic changes and their correlation 
with outcome of COVID-19 patients.  
Methods 
Study design and setting 
This Prospective cohort study was carried out on 
COVID-19 cases admitted to Shohadaye Tajrish 
Hospital, Tehran, Iran, during late February and 
March 2020. Electrocardiographic characteristics 
of patients were investigated and their association 
with in-hospital mortality was analysed. The study 
was approved by Ethics Committee of Shahid 
Beheshti University of Medical Sciences and 
researchers adhered to ethical practice and 
confidentiality of patients’ information. 
Selection of participants 
Hospitalized cases with confirmed COVID-19 
pneumonia based on chest CT scan and reverse 
transcription polymerase chain reaction (RT-PCR) 
were studied. Out of hospital mortality cases, 
pregnant women, and patients with history of 
congenital heart disease, as well as multiple trauma 
patients were excluded.  
Data Gathering and outcome  
A checklist that consisted of demographic variables 
(age, sex), comorbidities (hypertension, diabetes 
mellitus, ischemic heart disease, etc.), presenting 
vital signs (temperature, blood pressure, heart 
rate, respiratory rate, and O2 saturation), clinical 
manifestations, prescribed treatments, ECG 
variables, and outcomes (discharge, need for 
mechanical ventilation, and death) was filled out 
for all included patients. Data gathering and 
interpretation of ECGs were done by a cardiologist. 
For mitigating the possible effects of treatment on 
ECG characteristics (such as QT abnormality), the 
first ECG of patients obtained at the time of 
presenting to emergency department was used for 
interpretations. If an ECG abnormality, such as T 
wave abnormality, was repeated in at least two 
leads, the patient was considered positive for that 
abnormality. All of the 12-lead ECGs were 
performed with 10 mm (1 mV) amplitude and 25 
mm per second speed. Severity of disease was 
assessed using quick (sequential organ failure 
assessment score (SOFA score). Based on this 
score, patients with a score equal to or more than 2 
are categorized as high-risk for mortality. The main 
outcome studied in the present study was in-
hospital mortality. All patients were followed up 
during their hospitalization period. Patients were 
discharged from the hospital when their chest 
computed tomography (CT) scan findings were 
normal and the reverse transcription polymerase 
chain reaction (RT-PCR) analysis was negative for 
COVID-19. 
Statistical analysis 
Analyses were performed using STATA 14.0. The 
findings were presented as mean ± standard 
deviation or frequency (%). Cox regression was 
used to evaluate prognostic factors of mortality in 
COVID-19 patients. In the first step, using 
univariate analysis, the relationship between 
baseline variables and ECG findings with in-
hospital mortality was investigated. In the next 
step, all factors that had a probable relationship 
with mortality (p<0.1) were entered into a 
multivariate Cox regression model. Also, since 
previous studies had identified age and sex as risk 
factors for mortality in COVID-19 patients, the final 
analyses were adjusted for these two factors. 
P<0.05 was considered as the level of significance. 
RESULTS 
Characteristics of study subjects 
One hundred and nineteen cases with the mean age 
of 60.52 ± 13.45 (range: 29-89) years were studied 
(65.5% male). The highest number of patients were 
in the over 60 years age group. Table 1 shows the 
baseline characteristics of studied cases. 
Hypertension (33.4%) and Diabetes mellitus (28.6) 
were among the most frequent comorbidities 
among patients. The most frequent clinical 
symptoms of patients at the time of admission to 
emergency department were cough (73.1%), 
dyspnea (71.4%), and fever (53.8%), respectively.  
ECG findings 
Table 2 shows the detailed ECG findings of studied 
cases at the time of admission. Thirty-six (30.3%)  
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cases presented with tachycardia and 2 (1.7%) 
with bradycardia. Dysrhythmias were detected in 
22 (18.4%) cases. T-wave inversion (28.6%), 
pulmonale P-wave (19.3%), left axis deviation 
(19.3%), and ST-segment depression (16.8%) were 
among the most frequent detected ECG 
abnormalities, respectively. 
Outcomes 
The mean duration of hospitalization in this series 
was 7.54 ± 3.40 (range: 1-21) days. 104 (87.4%) 
cases were discharged from hospital, 16 (13.4%) 
were intubated and 12 (10.1%) died. 
Prognostic factor of Mortality  
Univariate analysis showed that there is a 
significant correlation between in-hospital 
mortality and history of diabetes mellitus 
(p=0.007), quick SOFA score > 2 (p<0.0001), 
premature ventricular contraction (PVC) 
(p=0.003), left axis deviation (LAD) (p=0.039), 
pulmonale P-wave (p<0.001), biphasic P wave 
(p<0.001), inverted T-wave (p=0.002), ST-
depression (p=0.027), and AV node block 
(p=0.002) (Table 2). Mean QT-interval on 
admission was 413.02±40.95 milliseconds in those 
who survived and 415.75±16.44 milliseconds in 
those who did not survive (p = 0.820). Multivariate 
cox regression showed that history of diabetes 
mellitus, presence of PVC and pulmonale P-wave 
were the most important independent prognostic 
factors of mortality in COVID-19 cases (Table 3).  
Table 1: Baseline characteristics of studied COVID-19 
cases 
Variable  Value 
Sex  
Male 78 (65.5) 
Female 41 (34.5) 
Age (year)  
20-39 10 (8.4) 
40-59 40 (33.6) 
≥ 60 69 (58.0) 
Comorbidity  
Diabetes mellitus 34 (28.6) 
Hypertension 40 (33.4) 
Ischemic heart disease 22 (18.5) 
Chronic kidney injury 18 (15.1) 
Smoking 35 (29.4) 
Clinical manifestations  
Fever 64 (53.8) 
Cough 87 (73.1) 
Dyspnea 85 (71.4) 
Nausea 19 (16.0) 
Diarrhea 11 (9.2) 
Presenting vital signs  
Temperature (°C)  37.43 ± 0.87 
SBP (mmHg) 120.68 ± 18.61 
DBP (mmHg) 75.14 ± 10.18 
Heart rate (/minute) 93.61 ± 19.67 
Respiratory rate (/minute) 20.10 ± 3.34 
O2 saturation 81.84 ± 9.36 
Data are presented as mean ± standard deviation or 
frequency (%). SBP: systolic blood pressure; DBP: diastolic 
blood pressure. 
 
Table 2: Univariate analysis for assessing the correlation of baseline characteristics and electrocardiogram (ECG) findings with 
mortality; Data are presented as mean ± standard deviation or frequency (%). 
Variable Alive n=107 Died n=12 Total n=119 p* 
Baseline characteristics    
Age (year) 59.8±13.0 67.4±16.0 60.5±13.5 
0.157 
20-39 9 (8.4) 1 (8.3) 10 (8.4) 
40-59 37 (34.6) 3 (25.0) 40 (33.6) 
≥ 60 61 (57.0) 8(66.7) 69 (58.0) 
Sex    
0.560 Male 71 (66.4) 7 (58.3) 78 (65.5) 
Female 36 (33.6) 5 (41.7) 41 (34.4) 
Smoking    
0.177 No 78 (72.9) 6 (50.0) 84 (70.6) 
Yes 29 (27.1) 6 (50.0) 35 (29.4) 
Diabetes mellitus    
0.007 No 81 (75.7) 4 (33.3) 85 (71.4) 
Yes 26 (24.3) 8 (66.7) 34 (28.57) 
Hypertension    
0.357 No 73 (68.2) 6 (50.0) 79 (66.4) 
Yes 34 (31.8) 6 (50.0) 40 (33.6) 
Ischemic heart disease    
0.239 No 89 (83.2) 8 (66.7) 97 (81.5) 
Yes 18 (16.8) 4 (33.3) 22 (18.5) 
Chronic kidney disease / End-stage renal disease   
0.934 No 91 (85.0) 10 (83.3) 101 (84.9) 
Yes 16 (15.0) 2 (16.7) 18 (15.1) 
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 Table 2 (in continue): Univariate analysis for assessing the correlation of baseline characteristics and electrocardiogram (ECG) 
findings with mortality; Data are presented as mean ± standard deviation or frequency (%). 
Variable Alive n=107 Died n=12 Total n=119 p* 
Quick SOFA score    
<0.001 
0 67 (62.6) 1 (8.3) 68 (57.1) 
1 36 (33.6) 5 (41.7) 41 (34.5) 
2 3 (2.8) 5 (41.7) 8 (6.7) 
3 1 (0.93) 1 (8.3) 2 (1.7) 
ECG findings     
Rate (beat/min) 97.3±21.7 92.0±31.1 96.8±22.7 
0.368 
Normal 74 (69.2) 7 (58.3) 81 (68.1) 
Tachycardia 32 (29.9) 4 (33.3) 36 (30.2) 
Bradycardia 1 (0.9) 1 (8.3) 2 (2.7) 
Rhythm     
Sinus rhythm 89 (83.2) 9 (75.0) 98 (82.3) 0.586 
Atrial tachycardia 3 (2.8) 1 (8.3) 4 (3.4) 0.597 
Atrial fibrillation 10 (9.4) 2 (16.7) 12 (10.1) 0.360 
Paroxysmal supraventricular tachycardia 5 (4.7) 1 (8.3) 6 (5.0) 0.778 
Premature complex     
Premature atrial contraction 13 (12.2) 2 (16.7) 15 (12.6) 0.872 
Premature ventricular contraction 15 (14.0) 7 (58.3) 22 (18.5) 0.003 
Axis deviation     
Right axis deviation 7 (6.5) 1 (8.3) 8 (6.7) 0.768 
Left axis deviation 16 (15.0) 5 (41.7) 21 (17.6) 0.039 
P wave abnormality     
P Pulmonale 15 (14.0) 8 (66.7) 23 (19.3) <0.001 
Biphasic P wave 10 (9.4) 6 (50.0) 16 (13.4) <0.001 
T wave abnormality     
Tall T wave 2 (1.9) 0 (0.0) 2 (1.7) >0.999 
Inverted T wave 25 (23.4) 9 (75.0) 34 (25.6) 0.002 
ST segment abnormality     
ST elevation 5 (4.7) 1 (8.3) 6 (5.0) 0.683 
ST depression 15 (14.0) 5 (41.7) 20 (16.8) 0.027 
Blocks     
Right bundle branch block 6 (5.6) 1 (8.3) 7 (5.9) 0.928 
Left bundle branch block 5 (4.7) 2 (16.7) 7 (5.9) 0.063 
Atrioventricular node block 0 (0.0) 1 (8.3) 1 (0.84) 0.002 
Sinus arrest 3 (5.0) 0 (0.0) 3 (4.5) >0.999 
Intervals     
PR prolongation (≥ 20ms) 21 (19.6) 5 (41.7) 26 (21.8) 0.132 
QTc day 1 (≥ 440ms) 28 (26.2) 1 (8.3) 29 (24.4) 0.289 
*Based on univariate cox regression. Bold values are significant.   
 
 
Table 3: Multivariate cox regression for assessing the correlation of baseline characteristics and electrocardiogram findings with 
mortality 
Variable 
Hazard ratio 95% confidence interval P 
Age 0.98 0.90-1.06 0.555 
Male sex 4.52 0.80-25.40 0.089 
Diabetes mellitus 56.87 2.58-1254.28 0.010 
Quick SOFA score≥2 1.34 0.24-7.37 0.734 
Premature ventricular contraction 18.44 2.20-154.30 0.007 
Left axis deviation 0.90 0.05-15.97 0.950 
P pulmonale 17.63 1.59-195.22 0.019 
Biphasic P wave 1.24 0.11-13.66 0.862 
Inverted P wave 7.44 0.73-73.36 0.089 
ST depression 1.65 0.22-12.21 0.625 
Left bundle branch block 2.91 0.07-113.93 0.568 
Atrioventricular node block 1.58 0.013-187.39 0.852 
Bold values are significant.  
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Kaplan-Meier survival graph for independent 
prognostic factors of COVID-19 mortality is 
presented in figure 1. Among the 12 patients who 
died, 2 (16.6%) had one prognostic factor, 9 
(75.0%) had two prognostic factors and 1 (8.3%) 
patient had 3 prognostic factors (table 4).  
DISCUSSION 
Based on the findings of the present study, 18.4% 
of patients with COVID-19 had presented with 
some kind of dysrhythmia and in addition to 
diabetes mellitus, presence of PVC and pulmonale 
p wave were among the independent prognostic 
factors of mortality in COVID-19 patients. Presence 
of pulmonale P wave is a consequence of increased 
pulmonary vascular resistance and right atrial 
dilatation (10). Increase in pulmonary vascular 
resistance can be either chronic or acute. 
Underlying pulmonary diseases and chronic 
obstructive pulmonary disease (COPD) are among 
the chronic causes of increase in pulmonary 
vascular resistance and formation of pulmonale P 
wave. On the other hand, ailments such as 
pulmonary embolism can acutely cause pulmonale 
P wave formation in the ECG. In other words, when 
an embolism is formed we will witness a right heart 
strain and acute cor pulmonale (11). There are 
studies that have reported a rise in the risk of 
pulmonary embolism following infection with 
COVID-19 (12, 13). The reason for this might be the 
high affinity of the COVID-19 virus to vascular 
endothelium, causing endothelial injury and paving 
the way for thrombosis (14). Additionally, some 
studies have shown that right atrial enlargement is 
one of the most important prognostic factors of 
mortality in pulmonary embolism patients with 
stable hemodynamics (15, 16). Whatever the cause 
for formation of pulmonale P wave, the situation is 
dangerous in nature for the affected patients. The 
present study shows that presence of PVC in ECG of 
COVID-19 patients on admission is associated with 
increased risk of mortality. Presence of PVC alone 
may indicate ischemia, ischemic cardiac 
dysfunction, and low cardiac reserve. Existing 
evidence show that myocardial infarction, 
myocarditis, and acute coronary syndrome are the 
most commonly observed disorders following 
COVID-19 infection (7). Presence of PVC can either 
be an underlying cardiac problem for the patient or 
can be caused as a direct or indirect effect of 
COVID-19 infection on the cardiovascular system. 
In a meta-analysis on the data of 4 original articles, 
which included the data of 341 patients, it was 
revealed that mean serum level of cardiac troponin 
I was significantly higher in patients with severe 
cases of COVID-19 compared to non-severe cases 
(6). Four cohort studies on hospitalized COVID-19 
patients in China showed that the rate of cardiac 
complications in hospitalized patients varies from 
7% to 17%. These studies showed that the 
prevalence of cardiac disorders in intensive care 
unit (ICU) admitted patients was 22.2%, while this 
rate was 2% in other patients. The interesting point 
is that the rate of cardiac disorders has been 
reported to be as high as 59% in patients who died, 
but about 1% in other patients (17-20). Therefore, 
whether PVC is a manifestation of the patient’s 
previous cardiac problems or a disorder caused by 
direct or indirect effects of COVID-19 on the 
cardiovascular system, its presence can be 
considered as an independent risk factor for 
mortality. Diabetes is another prognostic factor, 
which is associated with increased risk of mortality 
among patients. Diabetes is one of the most 
common comorbidities among COVID-19 patients 
(21). In the present study, diabetes was a 
   
Figure 1: Kaplan-Meier survival graph for independent prognostic factors of COVID-19 mortality 
 
Table 4: Correlation between presence of independent 
prognostic factors and mortality of COVID-19 patients 
Number of  
prognostic factor(s) 
Alive Dead 
0 57 (100.0) 0 (0.0) 
1 44 (95.6) 2 (4.4) 
2 6 (40.0) 9 (60.0) 
3 0 (0.0) 1 (100.0) 
Prognostic factors included diabetes mellitus, premature 
ventricular contraction (PVC), and P Pulmonale  
ADVANCED JOURNAL OF EMERGENCY MEDICINE. In press. Pishgahi et al 
   
 
6 Copyright © 2020 Tehran University of Medical Sciences  
This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). 
 
prognostic factor for mortality, while in the study 
by Zhou et al. it had no correlation with mortality 
of patients (22).  The reason for this difference 
could be the retrospective design of the study by 
Zhou et al. as well as differences between the 
Iranian and Chinese populations. Meanwhile, in 
another study on 1590 patients, a significant 
correlation was found between diabetes and 
undesirable outcome in COVID-19 patients (23). 
One of the probable mechanisms suggested for the 
relationship between COVID-19 and diabetes is the 
interaction of the virus with angiotensin-
converting enzyme 2, which is expressed in 
epithelial and vascular cells. It seems that diabetes 
leads to an increase in the expression of proteins in 
this pathway, which exacerbates the condition of 
the patient (21). However, this proposed 
mechanism has been challenged recently and there 
are doubts about it (24). Another mechanism that 
can be considered for diabetes in exacerbation of 
COVID-19 patients’ condition is its correlation with 
pulmonary embolism. Diabetes is one of the known 
risk factors of pulmonary embolism (22, 25). 
Presence of diabetes in COVID-19 patients can be a 
predisposing factor for pulmonary embolism and 
formation of numerous micro-emboli in pulmonary 
vessels. However, further studies are needed for 
confirming this hypothesis. One of the important 
points that should be considered regarding ECG 
changes in patients with COVID-19 is the QTc 
interval. We currently know that one of the side 
effects caused by commonly used drugs for treating 
these patients, i.e. hydroxychloroquine and some 
antiviral drugs, is increasing the QT interval. Since 
this can set the stage for formation of lethal 
dysrhythmia such as torsade de pointes and 
ventricular tachycardia, patients, especially those 
who have been hospitalized, should be monitored 
in this regard. 
Limitations 
One of the limitations of the present study was its 
relatively small sample size. However, it should be 
noted that the present study is one of the few 
prospective studies performed on COVID-19 
regarding ECG changes. In addition, in order to 
reach a more accurate conclusion regarding the 
weight of ECG findings in predicting the outcome of 
patients, a more comprehensive study including 
other known risk factors of death in these patients 
should better be performed so that more accurate 
data can be found. Another limitation of this study 
was using quick SOFA score instead of more 
accurate scales of disease severity. Severity of 
disease had better been evaluated using more 
accurate scales such as APACHE; however, 
considering the critical conditions of the hospital 
and the treatment team this could not be done. 
CONCLUSIONS 
Findings of the present study showed that 
evaluating ECG changes could provide the 
treatment team with good information on the 
patient’s prognosis. Considering the findings of the 
present study, it seems that ECG changes in 
patients presenting with COVID-19, whether they 
indicate underlying cardiac illnesses or are side 
effects of the infection, can affect the outcome of 
patients. Therefore, in times of doubt about 
managing the patient as an in-patient or an out-
patient, or when triage is required for allocation of 
equipment to more critical patients, considering 
ECG findings may help in selecting patients with 
higher risks. Based on the findings of the present 
study, 18.4% of COVID-19 patients had presented 
with some kind of dysrhythmia and in addition to 
history of diabetes, presence of PVC and pulmonale 
p wave were among the independent prognostic 
factors for mortality of COVID-19 patients. 
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